These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 8918691

  • 1. IL-12 promotes cellular but not humoral type II collagen-specific Th 1-type responses in C57BL/6 and B10.Q mice and fails to induce arthritis.
    Szeliga J, Hess H, Rüde E, Schmitt E, Germann T.
    Int Immunol; 1996 Aug; 8(8):1221-7. PubMed ID: 8918691
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
    Mauri C, Feldmann M, Williams RO.
    Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the adjuvant effect of IL-12 and efficacy of IL-12 inhibitors in type II collagen-induced arthritis.
    Germann T, Hess H, Szeliga J, Rüde E.
    Ann N Y Acad Sci; 1996 Oct 31; 795():227-40. PubMed ID: 8958934
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo.
    Germann T, Bongartz M, Dlugonska H, Hess H, Schmitt E, Kolbe L, Kölsch E, Podlaski FJ, Gately MK, Rüde E.
    Eur J Immunol; 1995 Mar 31; 25(3):823-9. PubMed ID: 7705414
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P, Li XY, Wang HK, Jia JF, Zheng ZH, Ding J, Fan CM.
    Clin Immunol; 2007 Jan 31; 122(1):75-84. PubMed ID: 17045846
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Suppression of murine collagen-induced arthritis by nasal administration of collagen.
    Myers LK, Seyer JM, Stuart JM, Kang AH.
    Immunology; 1997 Feb 31; 90(2):161-4. PubMed ID: 9135541
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CD28-deficient mice are highly resistant to collagen-induced arthritis.
    Tada Y, Nagasawa K, Ho A, Morito F, Ushiyama O, Suzuki N, Ohta H, Mak TW.
    J Immunol; 1999 Jan 01; 162(1):203-8. PubMed ID: 9886387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.